Flagship Pioneering secures Pentagon contract to develop biological threat countermeasures

Flagship Pioneering, a biotech investment firm, has been awarded a contract by the U.S. Department of Defense.

The contract aims to advance technologies that can serve as countermeasures against biological threats, reflecting growing interest in biosecurity.

The award highlights the intersection of biotech innovation and national defense priorities, and may attract further investment in related research.